more news! GoldNApel 10-17-13 Answers to Facebook

New Post Public Reply Private Reply Replies (3) Message Board
Budd Kind
more news!

GoldNApel 10-17-13
Answers to Facebook Questions.

Tom asked about CBD suppressing metastasis (invasive spreading) in cancer and if Dhrmanol™ works the same way.

Hi Tom,

Thanks for the question. Although Dr. Apel has a far greater understanding of the inner workings of the molecules than I, I think I can answer your questions here.

Dr. McAllister and his crew have done spectacular work with CBD, and vast amounts of research shows that the inhibition of the spreading of cancer is one of the chief attributes of the molecule.

Dr. McAllister and his group have been working with CBD almost exclusively, as have many other researchers in the field who have decided that the chances to actually be allowed to do research on cannabis were greatly increased if they concentrated on the non-psychoactives.

Demonstrating a significant inhibition of the metastasizing of breast cancer to the lungs was one of the positive results of the very first scientific studies on cannabis in the modern era. In 1975, the NIDA funded Munson and his crew at the Univ. of Virginia Medical Center to try to prove that marijuana caused cancer.

They proved just the opposite, in lab animals and in glass, and the phenomenal results of their study did not usher in a new era of cancer research, as we would expect; the results were buried, their funding withdrawn, and no future studies were allowed for twenty years. Some claim that the government actually contacted universities who had done a few studies and asked that the research be destroyed.

It took the small group led by Manuel Guzman at the University of Madrid to revive the experiments, and restart the modern scientific research, and, shortly thereafter, their efforts were joined by many other researchers around the world and the first experiments showing the efficacy of cannabinoid medicine were confirmed again and again … recently Harvard validated the tumor-fighting properties of cannabis medicine.

All of the politics have forced many researchers to focus on the non-psychoactives, that is why we have so much research on CBD. Also, medical research traditionally utilizes isolated and purified single-molecule medicines for study, as opposed to a blend of similar compounds such as the entire array of cannabinoids and related compounds found in marijuana and hemp.

Because of these two factors, many people attribute specific actions of cannabinoid medicine to specific molecules. THC does that, CBD does this, CBN does something altogether different, etc. While there is certainly a lot of truth in the specific actions of the different cannabinoids against various medical conditions, the ultimate benefit in treating the great majority of conditions that cannabis works well against comes from what we refer to as “whole-plant” medicine.

There are a number of different figures quoted for the number of chemical compounds that may have medicinal benefit in the cannabis plant. I like the number 421 … I figure they counted one of them twice. All the anecdotal evidence, as well as some of the scientific research, shows that cannabis medicine works better as a whole-plant preparation, providing the widest array of cannabinoids, terpenes, etc. that the plant has to offer in the medicine.

The exception to this is when psychoactive THC causes unwanted side effects that limit the amount of medicine that a patient can consume. In this case, it is helpful to eliminate the THC, as is the case with medicines focused on the delivery of pure CBD, or consume the THC in it’s carboxylate (non-psychoactive) form, as happens when one juices fresh cannabis plants, or uses Dharmanol™.

Berkeley Bio did not pioneer the use of the carboxylates in cannabis medicine. That honor belongs to Dr. William Courtney of Willits, CA. Another true hero of the movement, Dr. Courtney has been treating patients with fresh cannabis juice for years, and his wonderful results can be seen on a number of videos on YouTube.

The biggest drawback to Dr. Courtney’s work is that a patient must maintain forty to eighty living cannabis plants to get enough juice for the daily treatment. That isn’t that hard to do in Willits, California – the heart of the Emerald Triangle – but it can be impossible for someone who is not deeply immersed in the culture, or lives in another part of the country.

Dr. Apel’s new technology has allowed us to medicinalize the carboxylates, so they can be taken in tablet form … far more convenient than maintaining forty to eighty live cannabis plants. We have been able to extract and stabilize certain components of hemp/cannabis yielding an oil with about 60% mixed cannabinoids and less than .2 (point 2) percent THC. When this concentrate is tableted with 5 mg. of mixed cannabinoids, the amount of THC will be well below that in many of the health food products found on US shelves today.

Along with the 5 mg. of mixed cannabinoid carboxylates, each Dharmanol™ tablet also contains 5 mg. CBD, for a total of 10 mg. of mixed phyto-cannabinoids. Also included is a steam-extracted mixture of a wide array of terpenes and terpenoids, taken from a number of different strains of cannabis.

The medicinal activity of the cannabinoids is enhanced by the naturally-occuring terpenes and terpenoids in the plant. These are the molecules that are responsible for the taste and smell, and they vary greatly from plant to plant. There is the wonderful sweet smell of the strains called “pineapple”, the aroma of blueberry cannabis can be indistinguishable from that of the actual berry, and at the whole opposite end of the spectrum is the aptly named “Skunk #1”, winner of the very first High Times Cannabis Cup, and the marijuana which, in my opinion, provides the happiest high of all.

Certain terpenes and terpenoids found in the cannabis plant, as well as many other plants, have been tested for their medicinal efficacy. And … guess what? The medicinal efficacy of the ones found in cannabis is very, very promising. (Pardon my personal opinion here and let me again note that I will never claim cure until we have double-blind placebo-controlled proof, but I gotta ask myself: “Is there ANY part of this plant that doesn’t fight disease in every possible way it can?”. I can’t find one.)

The overall purpose of the Dharmanol™ technology, and the low-dose tablets in particular, is to combine many of the healing factors of the kind herb together into one medicine – a medicine which allows the patient to benefit from phyto-cannabinoid therapy stimulation of the internal cannabinoid receptors on a regular basis, with no THC psychoactivity.

At the opposite end of the spectrum is high dose cannabis therapy with Dharmanol™. The removal of the psychoactivity from larger doses allows consumption of doses far in excess of those recommended by Mr. Simpson. We have been working on appropriate delivery systems for whole-plant extracts and today announced Mary Ann’s Canna-Loz™ product , which makes the recommended gram each day regimen far more palatable. Shortly the Canna-Loz™ will be available in most of the dispensaries that carry YAK edibles, and the lozenges will supplement the Organakoil that the Care and Hospice Program has been supplying to patients in need for several years.

Mary Ann has always been the heart of the Care and Hospice Program, (even back when it was Dharma Patient’s Cooperative, Inc.) making sure that new patients were able to legally begin treatment as soon as they applied for help. She was also responsible for the interface between the patients, their caregivers, the doctors, etc. She has taken it as her personal mission to see that all the patients in the program are taken care of in the best possible manner, as soon as possible.

The absolute yuckiness (excuse the medical term and no puns, please) of taking cannabis rubbed on the gums is overwhelming, especially to a patient who is frail and has trouble keeping down food and fighting nausea. The relief of being able to slowly let a lozenge dissolve in the mouth is a great improvement.

And while Mary Ann had been working on this for a few months, it was recent events that caused us to bring it out now. Recently a friend of Liani’s had her 22 month-old son diagnosed with a brain tumor. There were numerous MRI’s, numerous doctors were consulted, and chemo was insisted upon by all, even though the doctors said the treatment would ruin the child’s quality of life, and would probably make little difference in treating the cancer.

Mom refused, went and got her own caregiver card, found the right private doctor to OK things, and started treating the child with Organakoil, and other cannabis products. The child responded well, but hated the oil. Mary Ann made a special batch of lozenges and the child was able to chew on a thin slice, which he liked. I will try to get Mary Ann and Liani to write a bit on this; it is a fascinating story. But suffice it to say here that, the cancer is gone … and the kid is doing great.

Another Question:

Brad asked if Dharmanol contained THC.

Here is how I replied:

Hi Brad,

To answer your question, Dharmanol does contain some active THC. It also contains a full spectrum of all the other cannabinoids contained in the source material. The big difference here is that the great bulk of the THC has been preserved (extracted and stabilized) in its non-psychoactive form as THCA. It will not get one "high".

While the total cannabinoids in each tablet is 10 mg., the amount of psychoactive THC in Dharmanol is less than that found in many hemp products that can be purchased at the health food or nutrition store.

The laws and regulations on THC in hemp-based health products are as convoluted as other parts of cannabis law. Right after the turn of the century, the DEA made a high-handed proclamation that no hemp products could exist in the US if they had any amounts of THC.

Thankfully, they were sued by a hemp advocacy group, led by David Bronner, son of Dr. Bronner of soap and health food fame, and the hemp forces won in around 2006. The court basically told the DEA to keep their hands off hemp-based products that were not meant to get someone high. And this is the situation we work under today ... and why we have hemp-based beer, salad dressing made from hemp oil, and a myriad of similar products.

Thanks for the questions, Please keep them coming. Sorry if I take a few days sometimes, or if I might miss some. Real busy these days.

Dave

SK3 Group Inc. (SKTO) Stock Research Links

SKTO Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ascletis' Preclinical Successes: Future of Obesity Treatment

Updated Category News Views 84

Pharma Giants Eyeing a New Potential Well, it seems the world of pharma is buzzing with Ascletis’ latest developments in the obesity treatment arena. They’ve just showcased some intriguing preclinical data at ObesityWeek® 2026. The standout? A cocktail of advancements that might just put a dent in the obesity epidemic if further studies pan out. ASC30_48: A Daily...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 41

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Loyalty Programs Cut $1500 Annually for Consumers

Updated Category News Views 56

Loyalty Programs: An Essential Tool for Households In a world where every dollar counts, retail loyalty programs have become more than just a marketing strategy—they're lifelines for American households scraping through each month. According to fresh research by the Retail Industry Leaders Association (RILA) and conducted by market research leader Circana, these...

Continue Reading
FDA Changes Shake Up Medtech Inspections Landscape

Updated Category News Views 75

Inspecting the Changing FDA Landscape If you’ve been treating FDA inspections like a ride down memory lane, it's time for a wake-up call. What F. David Rothkopf plans to tell the medical device teams at the MEDevice Silicon Valley event is simple: the game has changed. The FDA’s Quality Management System Regulation (QMSR) that kicked in on February 2, 2026, isn’t...

Continue Reading
Saint Luis Rey Launches Exclusive Palatinos Vitola

Updated Category News Views 34

New Beginnings for the Saint Luis Rey Brand You think you've seen it all in the cigar world, but then comes a debut like this that lights a fire under the lush tradition of Cuba. Enter Saint Luis Rey's new Palatinos vitola, a blend wrapped in the mystique of exclusivity for La Casa del Habano and Habanos Specialists. Whether you're a seasoned connoisseur or just dipping...

Continue Reading
NestWorks' C500: Shaking Up CNC at Formnext 2026

Updated Category News Views 120

NestWorks C500: A Game Changer for Makers Folks, gather 'round, because NestWorks is turning heads with their C500 desktop CNC machine. As it lands firmly on TIME’s Best Inventions of 2026 list, this ain't just another gadget adorning a workshop—all eyes are on it at Formnext 2026. From November 17–20, Frankfurt is the stage where NestWorks plans to showcase how...

Continue Reading
Home Energy Tips: Embrace the Electrical Panel Shift

Updated Category News Views 13

Why Electrical Panels Matter More Than Ever Back in the day, electrical panels weren't exactly the star of the homeowner show. But times have changed, and those previously mundane boxes of switches and wires now demand a spotlight. Shifts in modern lifestyles have catapulted electrical systems into the spotlight, making upgrades a pressing conversation topic for savvy...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 215

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Roche Delivers Endotrophin Assay to Nordic Bioscience Lab

Updated Category News Views 52

Roche Opens New Frontier in Diagnostic Biomarkers Get ready to chew on this: Roche Diagnostics is bringing something new to Nordic Bioscience's CLIA lab. They're offering up their Endotrophin research prototype assay on the cobas® e801 Analyzer. Now, what does this mean for the scientific world? Well, it might just shake things up for those battling cardiovascular and...

Continue Reading
Pine Tree Bets Big on Tulsa Hills Shopping Center

Updated Category News Views 85

Pine Tree's Latest Move in Retail Real Estate Ya ever watch a company make a move so aligned with its playbook that it feels like a script straight outta the boardroom? That's Pine Tree with its recent snag of Tulsa Hills Shopping Center for a cool $108 million. This ain't just any retail spot; it's a bustling hub nestled within the posh outskirts of Jenks, Oklahoma....

Continue Reading

Top 5 Most Recently Viewed Articles

Sunrise New Energy Unveils Innovative Solid-State Battery Patent

Updated Category News Views 205

Sunrise New Energy's Patent for Solid-State Battery Innovation Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) has made significant strides in energy technology with the announcement of a groundbreaking invention patent for a novel method of creating lithium cerate-coated graphite iron oxide anode material. This development is a significant leap forward in the realm of...

Continue Reading
Leadership Transition at Lykos Therapeutics Following FDA Setback

Updated Category News Views 103

Leadership Change at Lykos Therapeutics After FDA Setback Amy Emerson has resigned as CEO of Lykos Therapeutics following significant regulatory hurdles. This change comes after the Food and Drug Administration (FDA) recently rejected the company's application for its ecstasy-based therapy aimed at treating post-traumatic stress disorder (PTSD). Consequences of FDA...

Continue Reading
RADCOM to Showcase Innovations at Upcoming Growth Conference

Updated Category News Views 228

RADCOM to Showcase Innovations at Growth Conference RADCOM Ltd. (Nasdaq: RDCM) is gearing up for a prominent appearance at the 28th Annual Needham Growth Conference. The conference will take place at the esteemed Lotte NY Palace Hotel, where the company is excited to highlight its cutting-edge technological advancements. Leadership Team Participation At this significant...

Continue Reading
Shoppers Prioritize Savings Over Convenience, Survey Reveals

Updated Category News Views 81

New Insights into Consumer Preferences During Holidays A recent survey conducted by GoDaddy sheds light on the evolving preferences of consumers as the holiday season approaches. The findings reveal that convenience often takes a backseat to cost savings, which fundamentally impacts how businesses engage with their customers. The Importance of Cost Savings According to...

Continue Reading
Criteo's Insider Trading Insights: What You Need to Know

Updated Category News Views 116

Understanding Recent Insider Trading at Criteo Recently, significant insider trading activity has caught the attention of investors and analysts. Notably, Ryan Damon, Chief Legal Officer at Criteo, made headlines with a prominent stock sale involving his holdings in the company. Insider Sales: A Breakdown During a recent filing, it was disclosed that Ryan Damon sold 3,393...

Continue Reading